The Food and Drug Administration yesterday announced a firmware update to reduce the risk of rapid battery depletion and address cybersecurity vulnerabilities in certain Abbott devices that provide pacing for slow heart rhythms and electrical shock or pacing to stop dangerously fast heart rhythms. The update applies to several families of Abbott (formerly St. Jude Medical) implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators, including certain devices included in a 2016 recall related to premature battery depletion. FDA recommends that all eligible patients receive the firmware update at their next regularly scheduled visit or when appropriate, depending on the preferences of the patient and physician. Firmware is a type of software embedded in the hardware of a medical device.

Headline
F5, a technology company that specializes in multi-cloud application delivery and other services, disclosed six critical vulnerabilities Nov. 18 that were…
Headline
The AHA will host a webinar Dec. 2 at 1 p.m. ET that will explore strategies on protecting patient care, identifying critical systems that must remain…
Headline
Operational technology — which includes the network-connected devices that control physical systems like elevators and security systems — is often vulnerable…
Headline
An AHA Cybersecurity Advisory released Nov. 18 provides details on a Cybersecurity and Infrastructure Security Agency alert regarding a critical Java…
Headline
An FBI report released Nov. 13 details actions by cyber actors weaponizing ARTEX, an open-source, large language model-driven agentic artificial intelligence…
Headline
Brian Kaiser, supervisory special agent with the FBI’s Cyber Division, and Chad Beebe, deputy executive director of the American Society for Health Care…